ArticleEmerging infectious diseases2021
Reemergence of Scabies Driven by Adolescents and Young Adults, Germany, 2009-2018.
Article in Emerging infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 33 citations in OpenAlex.
- The rising burden of scabies in Italy: insights from a nationwide survey of dermatologists.Tropical medicine and health · 2026Article
- Head Lice: A Revised View of the Impact of the COVID-19 Pandemic on Transmission and Prevalence.Acta parasitologica · 2026Review
- Clinical presentation of scabies from 1996 to 2022: a retrospective cohort study from Finland.Scandinavian journal of primary health care · 2025Article
- Estimation of the epidemiological characteristics of scabies.Nature communications · 2025Review
- Rising scabies incidence in Spain: a retrospective observational analysis of four national data sources, 2011 to 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Observational
- Tracing the Itch: A Spatiotemporal Analysis of Scabies Rates and Its Risk Factors Using the Global Burden of Disease 2021 Data.Tropical medicine & international health : TM & IH · 2025Article
- Increasing trend of scabies in Belgium, 2000-2023.Archives of public health = Archives belges de sante publique · 2025Article
- Scabies Management Outcomes: Identification of Risk Factors for Treatment Success or Failure.Dermatology practical & conceptual · 2025Article
- Resurgence of scabies in Italy: The new life of an old disease.Parasite epidemiology and control · 2024Article
- Article
- Prevalence of scabies and its associated environmental risk factors among the Forcibly Displaced Myanmar Nationals living in the Cox's Bazar district of Bangladesh.Journal of migration and health · 2024Article
- Article
- Infection Control among Healthcare Workers and Management of a Scabies Outbreak in a Large Italian University Hospital.Journal of clinical medicine · 2023Article
- Increased Scabies Incidence at the Beginning of the 21st Century: What Do Reports from Europe and the World Show?Life (Basel, Switzerland) · 2022Review
- Article
- Demographic Characteristics, Clinical Presentations, and Dermoscopic Patterns among Patients with Scabies at a Nigerian Tertiary Hospital: A Cross-Sectional Study.Nigerian medical journal : journal of the Nigeria Medical AssociationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To validate anecdotal evidence on scabies infestations, we analyzed inpatient and outpatient claims data in Germany. Scabies diagnoses increased 9-fold and treatment failure 4-fold during 2009-2018, driven mainly by persons 15-24 years of age. Prevention and control in young adults appear key because of these persons' high mobility and social connectivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.